Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 629

Similar articles for PubMed (Select 18223328)

1.

Calretinin expression in the differential diagnosis of human ameloblastoma and keratocystic odontogenic tumor.

DeVilliers P, Liu H, Suggs C, Simmons D, Daly B, Zhang S, Raubenheimer E, Larsson A, Wright T.

Am J Surg Pathol. 2008 Feb;32(2):256-60. doi: 10.1097/PAS.0b013e3181452176.

PMID:
18223328
2.

Use of calretinin in the differential diagnosis of unicystic ameloblastomas.

Coleman H, Altini M, Ali H, Doglioni C, Favia G, Maiorano E.

Histopathology. 2001 Apr;38(4):312-7.

PMID:
11318896
3.

Comparative expression of calretinin in selected odontogenic tumours: a possible relationship to histogenesis.

Alaeddini M, Etemad-Moghadam S, Baghaii F.

Histopathology. 2008 Feb;52(3):299-304. doi: 10.1111/j.1365-2559.2007.02948.x.

PMID:
18269580
4.

Calretinin expression in ameloblastomas.

Altini M, Coleman H, Doglioni C, Favia G, Maiorano E.

Histopathology. 2000 Jul;37(1):27-32.

PMID:
10931215
5.

Perlecan-rich epithelial linings as a background of proliferative potentials of keratocystic odontogenic tumor.

Tsuneki M, Cheng J, Maruyama S, Ida-Yonemochi H, Nakajima M, Saku T.

J Oral Pathol Med. 2008 May;37(5):287-93. doi: 10.1111/j.1600-0714.2007.00620.x. Epub 2008 Jan 17.

PMID:
18205742
6.

The immunoprofile of odontogenic keratocyst (keratocystic odontogenic tumor) that includes expression of PTCH, SMO, GLI-1 and bcl-2 is similar to ameloblastoma but different from odontogenic cysts.

Vered M, Peleg O, Taicher S, Buchner A.

J Oral Pathol Med. 2009 Aug;38(7):597-604. doi: 10.1111/j.1600-0714.2009.00778.x. Epub 2009 Apr 16.

PMID:
19473442
7.

[Studies on keratocystic odontogenic tumors].

Li TJ, Sun LS, Luo HY, Yuan JW, Gao L, Gu XM, Li XF, Xu LL.

Beijing Da Xue Xue Bao. 2009 Feb 18;41(1):16-20. Chinese.

8.

Significance of podoplanin expression in keratocystic odontogenic tumor.

Okamoto E, Kikuchi K, Miyazaki Y, González-Alva P, Oku Y, Tanaka A, Yoshida N, Fujinami M, Ide F, Sakashita H, Kusama K.

J Oral Pathol Med. 2010 Jan;39(1):110-4. doi: 10.1111/j.1600-0714.2009.00851.x. Epub 2009 Nov 18.

PMID:
19925582
9.

Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts.

da Silva TA, Batista AC, Mendonça EF, Leles CR, Fukada S, Cunha FQ.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Mar;105(3):333-41. Epub 2007 Dec 3.

PMID:
18061491
10.

Expression of cell cycle and apoptosis-related proteins in ameloblastoma and keratocystic odontogenic tumor.

Metgud R, Gupta K.

Ann Diagn Pathol. 2013 Dec;17(6):518-21. doi: 10.1016/j.anndiagpath.2013.06.006. Epub 2013 Oct 1.

PMID:
24090509
11.

Expressions of bax, bcl-2 and Ki-67 in odontogenic keratocysts (Keratocystic Odontogenic Tumor) in comparison with ameloblastomas and radicular cysts.

Soluk Tekkeşın M, Mutlu S, Olgaç V.

Turk Patoloji Derg. 2012;28(1):49-55. doi: 10.5146/tjpath.2012.01097.

12.

[Expression of HOXC13 in ameloblastoma].

Zhong M, Wang J, Gong YB, Li JC, Zhang B, Hou L.

Zhonghua Kou Qiang Yi Xue Za Zhi. 2007 Jan;42(1):43-6. Chinese.

PMID:
17331444
13.

Diffusion-weighted MR imaging of ameloblastomas and keratocystic odontogenic tumors: differentiation by apparent diffusion coefficients of cystic lesions.

Sumi M, Ichikawa Y, Katayama I, Tashiro S, Nakamura T.

AJNR Am J Neuroradiol. 2008 Nov;29(10):1897-901. doi: 10.3174/ajnr.A1266. Epub 2008 Aug 21.

14.

p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas.

Kumamoto H, Izutsu T, Ohki K, Takahashi N, Ooya K.

J Oral Pathol Med. 2004 May;33(5):292-9.

PMID:
15078490
15.

[Ameloblastomas in the growth period--aspects of differential diagnosis and therapy].

Ehrenfeld M, Donath K, Riediger D, Mast G, Gärtner HV.

Dtsch Zahnarztl Z. 1991 Jan;46(1):77-9. German.

PMID:
1811982
16.

miR-15a/16-1 influences BCL2 expression in keratocystic odontogenic tumors.

Diniz MG, Gomes CC, de Castro WH, Guimarães AL, De Paula AM, Amm H, Ren C, MacDougall M, Gomez RS.

Cell Oncol (Dordr). 2012 Aug;35(4):285-91. doi: 10.1007/s13402-012-0087-3. Epub 2012 Jun 9.

PMID:
22684875
17.

Analysis of the neoplastic nature and biological potential of sporadic and nevoid basal cell carcinoma syndrome-associated keratocystic odontogenic tumor.

Katase N, Nagatsuka H, Tsujigiwa H, Gunduz M, Tamamura R, Pwint HP, Rivera RS, Nakajima M, Naomoto Y, Nagai N.

J Oral Pathol Med. 2007 Oct;36(9):550-4.

PMID:
17850439
18.

Expression of extracellular matrix proteins in ameloblastomas and adenomatoid odontogenic tumors.

de Medeiros AM, Nonaka CF, Galvão HC, de Souza LB, Freitas Rde A.

Eur Arch Otorhinolaryngol. 2010 Feb;267(2):303-10. doi: 10.1007/s00405-009-0996-6. Epub 2009 May 23.

PMID:
19466441
19.

Calretinin as a diagnostic adjunct for ameloblastoma.

Anandani C, Metgud R, Singh K.

Patholog Res Int. 2014;2014:308240. doi: 10.1155/2014/308240. Epub 2014 Apr 15.

20.

Immunohistochemical analysis of P63 expression in odontogenic lesions.

Atarbashi Moghadam S, Atarbashi Moghadam F, Mokhtari S, Eini E.

Biomed Res Int. 2013;2013:624176. doi: 10.1155/2013/624176. Epub 2013 Nov 24.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk